David Pauling's most recent trade in Sutro Biopharma Inc was a trade of 7,200 Stock Option (right to buy) done . Disclosure was reported to the exchange on Dec. 23, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sutro Biopharma Inc | David Pauling | Chief Admin. Ofcr. & GC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 7,200 | 7,200 | - | - | Stock Option (right to buy) | |
| Sutro Biopharma Inc | David Pauling | Chief Admin. Ofcr. & GC | Purchase of securities on an exchange or from another person at price $ 0.80 per share. | 15 Oct 2025 | 12,504 | 71,737 (0%) | 0% | 0.8 | 9,993 | Common Stock |
| Sutro Biopharma Inc | David Pauling | Chief Admin. Ofcr. & GC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2025 | 101,500 | 101,500 | - | - | Stock Option (Right to Buy) | |
| Sutro Biopharma Inc | David Pauling | Chief Admin. Ofcr. & GC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2025 | 94,250 | 94,250 | - | - | Restricted Stock Units (RSUs) |